Black Diamond Therapeutics Inc (BDTX) Ownership

$1.31

$0.08 (-5.76%)
Last update: 02:08 PM EST
Day's range
$1.31
Day's range
$1.41

Black Diamond Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEA MANAGEMENT COMPANY, LLC 11/16/2026 4.45 M $8.39 M   0.00% 7.75%
BLACKROCK, INC. 11/13/2026 4.30 M $8.11 M   9.79% 7.50%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/16/2026 3.93 M $7.40 M   -2.54% 6.84%
ACADIAN ASSET MANAGEMENT LLC 11/09/2026 2.35 M $4.42 M   0.00% 4.09%
VANGUARD CAPITAL MANAGEMENT LLC 11/13/2026 2.13 M $4.01 M   0.00% 3.70%
BANK OF AMERICA CORP /DE/ 11/16/2026 2.05 M $3.86 M   395.22% 3.57%
DEFILADE CAPITAL MANAGEMENT, L.P. 11/16/2026 1.77 M $3.34 M   5.73% 3.09%
RENAISSANCE TECHNOLOGIES LLC 11/12/2026 1.65 M $3.11 M   -15.81% 2.88%
GEODE CAPITAL MANAGEMENT, LLC 11/06/2026 1.25 M $2.35 M   2.31% 2.17%
MARSHALL WACE, LLP 11/13/2026 1.18 M $2.22 M   31.20% 2.05%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/10/2026 1.12 M $2.12 M   2.73% 1.96%
DIMENSIONAL FUND ADVISORS LP 11/04/2026 955.80 K $1.80 M   -30.00% 1.67%
STATE STREET CORP 11/12/2026 943.26 K $1.78 M   79.66% 1.64%
AQR CAPITAL MANAGEMENT LLC 11/16/2026 889.63 K $1.68 M   100.00% 1.55%
MORGAN STANLEY 11/13/2026 776.95 K $1.46 M   236.05% 1.35%
FMR LLC 11/10/2026 746.34 K $1.41 M   15.95% 1.30%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/16/2026 735.30 K $1.39 M   -7.09% 1.28%
GOLDMAN SACHS GROUP INC 11/16/2026 687.55 K $1.30 M   138.09% 1.20%
AWM INVESTMENT COMPANY, INC. 11/13/2026 650.00 K $1.23 M   -35.00% 1.13%
VANGUARD PORTFOLIO MANAGEMENT LLC 11/13/2026 414.85 K $781.99 K   1.91% 0.72%
NORTHERN TRUST CORP 11/16/2026 361.55 K $681.52 K   -1.05% 0.63%
EMPOWERED FUNDS, LLC 11/13/2026 358.81 K $676.36 K   44.60% 0.63%
UBS GROUP AG 11/10/2026 345.98 K $652.17 K   30.40% 0.60%
VANGUARD FIDUCIARY TRUST CO 11/13/2026 340.60 K $642.04 K   9.92% 0.59%
BANK OF NEW YORK MELLON CORP 11/05/2026 308.01 K $580.60 K   -3.37% 0.54%
STIFEL FINANCIAL CORP 11/12/2026 289.43 K $545.58 K   2.91% 0.50%
D. E. SHAW & CO., INC. 11/16/2026 278.47 K $524.91 K   76.99% 0.49%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11/12/2026 166.55 K $316.45 K   -42.34% 0.29%
BANQUE CANTONALE VAUDOISE 11/12/2026 147.22 K $278.00 K   100.00% 0.26%
BARCLAYS PLC 11/06/2026 143.99 K $271.42 K   259.47% 0.25%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/16/2026 128.42 K $242.07 K   19.25% 0.22%
PANAGORA ASSET MANAGEMENT INC 11/12/2026 124.50 K $234.68 K   -57.82% 0.22%
XTX TOPCO LTD 11/16/2026 112.43 K $211.93 K   153.78% 0.20%
BNP PARIBAS FINANCIAL MARKETS 11/12/2026 106.93 K $201.56 K   1,232.12% 0.19%
CANADA PENSION PLAN INVESTMENT BOARD 11/16/2026 103.60 K $195.29 K   0.00% 0.18%
RB CAPITAL MANAGEMENT, LLC 11/17/2026 100.00 K $188.50 K   0.00% 0.17%
BALYASNY ASSET MANAGEMENT L.P. 11/16/2026 87.31 K $164.59 K   -83.90% 0.15%
RITHOLTZ WEALTH MANAGEMENT 11/05/2026 79.18 K $149.26 K   -55.63% 0.14%
AMERICAN CENTURY COMPANIES INC 11/20/2026 78.25 K $147.49 K   -3.77% 0.14%
INVESCO LTD. 11/12/2026 69.04 K $130.14 K   -47.56% 0.12%
NUVEEN, LLC 11/10/2026 67.39 K $127.03 K   3.99% 0.12%
RAYMOND JAMES FINANCIAL INC 11/12/2026 67.06 K $126.41 K   7.75% 0.12%
SEI INVESTMENTS CO 11/10/2026 58.31 K $109.92 K   46.95% 0.10%
LOS ANGELES CAPITAL MANAGEMENT LLC 11/12/2026 58.03 K $109.38 K   100.00% 0.10%
JANE STREET GROUP, LLC 11/12/2026 51.29 K $96.68 K   -82.30% 0.09%
TWO SIGMA INVESTMENTS, LP 11/16/2026 40.60 K $76.54 K   -3.32% 0.07%
DEUTSCHE BANK AG\ 11/06/2026 40.26 K $76.09 K   -12.55% 0.07%
CITIGROUP INC 11/04/2026 40.13 K $75.65 K   73.47% 0.07%
PRICE T ROWE ASSOCIATES INC /MD/ 11/16/2026 39.28 K $75.00 K   0.00% 0.07%
HSBC HOLDINGS PLC 11/16/2026 37.54 K $71.33 K   42.09% 0.07%

Black Diamond Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 134 institutional investors and hedge funds held shares of Black Diamond Therapeutics Inc. The most heavily invested institutionals were:

NEA Management Company, LLC: 4.45 M

BlackRock, Inc.: 4.3 M

T. Rowe Price Investment Management, Inc.: 3.93 M

ACADIAN ASSET MANAGEMENT LLC: 2.35 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.13 M

BANK OF AMERICA CORP /DE/: 2.05 M

65.89% of Black Diamond Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 45.10 M shares in the last 24 months. This purchase volume represents approximately $59.08 M in transactions.